ArticleBJUI compass2026
Video-endoscopic versus open inguinal lymphadenectomy: Long-term oncological outcomes in penile cancer.
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07391514 (Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma: A Prospective Cohort Study
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lymph node metastasis status is the strongest predictive factor for penile cancer survival. In penile cancer patients with suspected lymph node involvement, inguinal lymph node dissection (ILND) extends disease-free survival. Though video-endoscopic ILND (VEILND) has demonstrated superior surgical outcomes to open ILND (OILND) in the short term, its oncological efficacy long term is unproven. We present our long-term oncological follow-up of our previously published ILND cohort. Methods: A prospectively collected institutional database was used to determine the outcome in 42 consecutive patients treated for penile cancer in a tertiary referral centre between 2008 and 2015. Overall survival and cancer-specific survival (CSS) were calculated using Kaplan-Meier curves and compared via log-rank tests. Results: Forty-two patients underwent 68 ILND (35 OILND vs. 33 VEILND). Thirteen out of 42 patients were alive at a mean follow-up of 12.5 years. Overall survival for OILND and VEILND was 36.4% and 30.0% at 10 years. There was no significant difference between the survival curves ( Conclusion: To our knowledge, we present the first European report of long-term follow-up demonstrating the oncological safety of VEILND. VEILND has comparable outcomes of recurrence, overall survival and CSS, with significantly reduced complication rates and length of stay, in penile cancer at a median follow-up of 104 months (range 2-213 months).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.